How to sleep like a baby with myLoop
For adults living with diabetes, achieving restful sleep can be difficult due to a variety of reasons. The Automated Insulin Delivery (AID) system myLoop helps maintaining stable glucose levels throughout the night, reducing the risk of nocturnal hypoglycaemia or hyperglycaemia1,2,3. A restful night supports you to wake up feeling refreshed and ready to face the day ahead.
A late meal, alcohol consumption, or a particularly stressful or active day can lead to unpredictable glucose fluctuations, making it difficult to get a good night’s rest. These factors make managing diabetes at night particularly challenging.
Achieving stable glucose levels throughout the night
myLoop's predictive and adaptive algorithm helps to deal with these challenges. By continually adjusting insulin delivery based on real-time Continuous Glucose Monitor (CGM) readings and predicted glucose levels, myLoop assists minimising the risk of nocturnal hypo- or hyperglycaemia, consequently achieving more stable glucose levels throughout the night1,2,3. By avoiding the physical strain of glucose highs and lows, your mornings will naturally start on a positive note.
Personalised comfort with myLoop
The CamAPS FX app hosting the algorithm offers a range of personalised settings, including:
Alarm settings: possibility to set a different alert schedule for the night minimising night disruptions.
Glucose targets: set the personal glucose target that meets your individual activity levels and needs.
Adaptive insulin delivery: whether it is compensating for a high-protein dinner, alcohol intake, or the physical strain of an active day, the CamAPS FX algorithm will adapt to your current needs.
By supporting stable glucose levels1,2,3 and minimising disruptions at night, myLoop supports you to enjoy a more restorative sleep and wake up feeling ready to embrace the day with confidence and vitality.
For safety information on mentioned products, see mylife-diabetescare.com/safety
* Companion remote monitoring is compatible with Android smartphones running OS 8 and above or OS 10 and above (as of January 2025). Internet connectivity is required to share data with ”companions”.
1. Barnard K. D. et al.: Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting. Diabet Med. 2015 May;32(5):601-8. DOI: 10.1111/dme.12706.
2. Barnard K. D. et al.: Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy. J Diabetes Sci Technol. 2017 Nov;11(6):1080-1088. DOI: 10.1177/1932296817702656.
3. Boughton C. K. et al.: Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study. Lancet Healthy Longev. 2022 Mar;3(3):e135–e142. DOI: 10.1016/S2666-7568(22)00005-8.
Disclaimer
The product images are for illustrative purposes only.
mylife and YpsoPump are registered trademarks of Ypsomed AG in several countries.
CamAPS is a registered trademark of CamDiab Ltd.
Dexcom and Dexcom G6 are registered trademarks of Dexcom, Inc. in the United States and/or other countries.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by mylife Diabetes Care is under license.
Other trademarks are the property of their respective owners.
myLoop: The innovation described is available in selected countries and expanding to further countries soon. Expansion is contingent upon local regulatory approval.
Insulin pumps and Automated Insulin Delivery (AID) systems can greatly improve glucose management but do not eliminate the risk of diabetic ketoacidosis (DKA). Because these systems use only rapid-acting insulin, any interruption in insulin delivery (e.g. infusion set failure, pump occlusion, empty reservoir, or device malfunction) can rapidly lead to ketosis and DKA - even if glucose readings are not very high. DKA is a serious and potentially life-threatening condition.
If you feel unwell, have persistent high glucose levels or detect positive ketones, please immediately contact your diabetes team and follow their advice. Do not rely solely on the AID system to correct high glucose or clear the ketones. Always check that insulin is being delivered and use your backup insulin method (e.g. insulin injections or insulin pens), if needed.
Medical advice can only be provided by healthcare professionals. The information contained in this material is intended for general educational purposes and should not be interpreted as medical advice or used as a substitute for consultation with a qualified healthcare professional.